HighField Biopharmaceuticals Announces First Patient Dosed in Phase 1b/2 Trial of HF1K16 for Recurrent and Refractory Glioma
HF1K16 is a new immuno-oncology drug targeting myeloid-derived suppressor cells (MDSC) to treat cancer HANGZHOU,…
HF1K16 is a new immuno-oncology drug targeting myeloid-derived suppressor cells (MDSC) to treat cancer HANGZHOU,…
Study met primary endpoint (p=0.000039); VYVGART® Hytrulo demonstrated 61% reduction (HR: 0.39 95% CI: 0.25;…
CHICAGO & SYDNEY--(BUSINESS WIRE)--James Hardie Industries plc (ASX: JHX; NYSE: JHX) will announce financial results,…
SHENZHEN, China--(BUSINESS WIRE)--The long-awaited DRAGBAR BF600, the latest launched mini shaped disposable e-cigarette in the…
The ‘Baby Come Back’ launch is scheduled to lift off from Rocket Lab Launch Complex…
BEIJING--(BUSINESS WIRE)--#BRI--On July 13, 2023, the completion ceremony of the Dasherkandi Sewerage Treatment Plant (DSTP)…
DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Automakers' Modular Platform and Technology Planning Research Report, 2023" report…
DUBLIN--(BUSINESS WIRE)--The "APAC Data Center Market Landscape 2023-2028" report has been added to ResearchAndMarkets.com's offering.…
NEW YORK--(BUSINESS WIRE)--On July 12th, the opening day of China Energy Guohua Investment Europe Renewable…
SHANGHAI, China and CAMBRIDGE, Mass., July 14, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:…